CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Supernus, Indivior to merge and form CNS-focused drugmaker

Positive
AI Analysis

Summary

Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to merge in an all-stock transaction, creating a combined CNS-focused company that will retain the Supernus name and be based in Rockville, MD.

Importance:7/10
Sentiment:
0.50
M&AmergerCNSall-stock deal
Related Companies

Read the original article

Published by Endpoints News on August 3, 2026 11:24 AM

Read Original